MoneyWorks4Me

The sales declined to Rs. 7.96 millions for the September 2023 quarter as compared to Rs. 9.28 millions during the corresponding quarter last year.The Company has registered profit of Rs. 5.61  millions for the quarter ended September 2023, a growth of 7.47%  over Rs. 5.22 millions millions achieved in the corresponding quarter of last year.Operating profit for the quarter ended September 2023 decreased to 6.34 millions as compared to 6.79 millions of corresponding quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 7.96 9.28 -14.22 25.00 21.20 17.92 37.07 1.27 2818.90
Other Income 19.65 19.91 -1.31 31.46 44.00 -28.50 105.34 395.35 -73.36
PBIDT 6.34 6.79 -6.63 -13.35 16.57 -180.57 53.76 339.68 -84.17
Interest 0.44 0.08 450.00 0.69 0.41 68.29 1.07 2.47 -56.68
PBDT 5.90 6.71 -12.07 -14.04 15.73 -189.26 44.81 36.44 22.97
Depreciation 0.29 0.43 -32.56 0.58 0.85 -31.76 1.45 1.92 -24.48
PBT 5.61 6.28 -10.67 -14.62 14.88 -198.25 43.36 34.52 25.61
TAX 0.00 1.06 -100.00 0.00 1.11 -100.00 2.26 4.96 -54.44
Deferred Tax 0.00 1.06 -100.00 0.00 1.11 -100.00 2.26 7.46 -69.71
PAT 5.61 5.22 7.47 -14.62 13.77 -206.17 41.10 29.56 39.04
Equity 766.33 766.33 0.00 766.33 766.33 0.00 766.33 766.33 0.00
PBIDTM(%) 79.65 73.17 8.86 -53.40 78.16 -168.32 145.02 26746.46 -99.46
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..